<!DOCTYPE html>
<html manifest="manifest.manifest">
<head>
	<meta http-equiv=Content-Type content="text/html; charset=utf-8">
	<title>MRCG Clinical Guidelines</title>
	<meta name="viewport" content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=2.0, user-scalable=1">
  
	<meta name=Generator content="Microsoft Word 14 (filtered)">
	<link rel="manifest" href="/manifest.json">	
	<link rel="stylesheet" href="jquery.mobile-1.4.5.min.css" />
	<link rel="stylesheet" href="mystyle.css" />
	<script src="jquery-1.11.1.min.js"></script>
	<script src="jquery.mobile-1.4.5.min.js"></script>
	<script type="text/javascript" src="cordova.js"></script>
	<script>
	    		$(function(){
			$("[data-role='header'], [data-role='footer']").toolbar();
		});
  	  $(document).one('pagebeforecreate', function () {
	        $('input[data-type="search"]').val("");
	    	        $.get("panel.html", function (data2) {
            $.mobile.pageContainer.prepend(data2);
              $("[data-role=panel]").panel().enhanceWithin();
        }, "html");
	           $.get("header.html", function (data) {
      $.mobile.pageContainer.prepend(data);
      $("[data-role='header']").toolbar().enhanceWithin();
    }, "html");
    $.get("footer.html", function (data) {
      $.mobile.pageContainer.append(data);
      $("[data-role='footer']").toolbar().enhanceWithin();
    }, "html");
        $('.WordSection1').wrap('<div role="main" class="ui-content">');
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $.mobile.pageContainer.enhanceWithin();
	  });
	        $(document).bind( "pagechange", function( ) {
        $('table').wrap('<div class="tableCont"></div>');
        $('img').wrap('<div class="tableCont"></div>');
        $('.tableCont').enhanceWithin();
      } );
			// When the user scrolls down 20px from the top of the document, show the button
		window.onscroll = function() {scrollFunction()};
		function scrollFunction() {
		  if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
			document.getElementById("myBtn").style.display = "block";
		  } else {
			document.getElementById("myBtn").style.display = "none";
		  }
		}
		// When the user clicks on the button, scroll to the top of the document
		function topFunction() {
		  document.body.scrollTop = 0; // For Safari
		  document.documentElement.scrollTop = 0; // For Chrome, Firefox, IE and Opera
		}
	</script>  
</head>

<body lang=EN-GB link=blue vlink=purple>

<div class=WordSection1>

<h1>Adults with mild or moderate COVID-19</h1>

<p class=paragraph style='vertical-align:baseline'><span class=normaltextrun><b><i><span
style='font-family:"Arial","sans-serif"'>Executive summary</span></i></b></span></p>

<p class=paragraph style='vertical-align:baseline'><span class=normaltextrun><b><span
style='font-family:"Arial","sans-serif"'>Introduction</span></b></span><span
class=eop><b>&nbsp;</b></span></p>

<p class=paragraph style='vertical-align:baseline'><span style='font-size:11.0pt;
font-family:"Arial","sans-serif"'>In late December 2019, the World Health
Organization (WHO) China Country Office was informed of cases of pneumonia of
unknown cause detected in Wuhan City, China. On 7 January 2020, the causative
pathogen was identified as a novel coronavirus (SARS-CoV-2). The disease
(COVID-19) can range from an symptomatic or mild flu-like illness to a severe
pneumonia requiring critical care. It was declared a pandemic by WHO on 11<sup>th</sup>
March 2020. </span></p>

<p class=paragraph style='vertical-align:baseline'><span class=normaltextrun><b><span
style='font-family:"Arial","sans-serif"'>Target User</span></b></span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span class=normaltextrun>Doctors</span></p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span class=normaltextrun>Nurses</span></p>

<p class=paragraph style='vertical-align:baseline'><span class=normaltextrun><b><span
style='font-family:"Arial","sans-serif"'>Target area of use</span></b></span></p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Outpatient department</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span class=normaltextrun>Ward</span></p>

<h2>Key areas of focus / New additions / Changes&nbsp;&nbsp;</h2>

<p class=paragraph style='vertical-align:baseline'><span class=normaltextrun><span
style='font-size:11.0pt;font-family:"Arial","sans-serif"'>These guidelines </span></span><span
style='font-size:11.0pt;font-family:"Arial","sans-serif"'>addresses the
diagnosis and management of low risk adults with COVID-19 who are mainly those
under the age of 60 with no serious underlying health conditions.</span></p>

<p class=paragraph style='vertical-align:baseline'><span class=normaltextrun><b><span
style='font-family:"Arial","sans-serif"'>Limitations</span></b></span></p>

<p class=MsoNormal>We lack access to HDU/ICU level care and cannot ventilate
patients.</p>

<p class=MsoNormal>We have only two negative pressure ward side rooms.</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<h2><a name="_Hlk35758971">&nbsp;</a></h2>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>

<h2>Management in the Gate clinic or at registration to OPD</h2>

<p class=MsoNormal>Patients should be asked as a group and individually at
registration if they have a history of travel to areas with local transmission
of SARS-CoV-2 in the last four weeks and if they have a fever, cough or
shortness of breath. </p>

<p class=MsoNormal>When the number of people having a dry cough in the gate
clinic and OPD waiting areas are more than usual, please have a heightened
index of suspicion. The travel history inquiry must be repeated before
consultation starts in the gate clinic and also during vital signs assessment at
the OPD by the nurses. If the answer to both questions is yes, do not touch the
patient. Give them a surgical mask and take them to a place 2 metres from other
people. Immediately inform a doctor or senior nurse who will wear a mask,
goggles and gloves and verbally screen the patient from a safe distance. If the
risk for COVID-19 is significant, a call is immediately placed to the COVID-19 national
number on 1025. A health worker in facemask and gloves must be left watching
over the patient. If there is no risk for COVID-19, the patient is taken care
of in the usual manner. </p>

<p class=MsoNormal><u>Epidemiological criteria- </u><b><i>Please note that this
is dynamic and it changes everyday</i></b></p>

<p class=MsoNormal>Those that have travelled from the countries with ongoing
presumed community transmission of COVID-19 disease in the 4 weeks prior to
onset of symptoms. (See WHO website for the latest list of relevant countries:</p>

<p class=MsoNormal><span lang=EN-US><a
href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports</a></span>)</p>

<p class=MsoNormal>OR</p>

<p class=MsoNormal>Contact with a confirmed case of COVID-19</p>

<p class=MsoNormal>OR </p>

<p class=MsoNormal>Patient has worked or attended a heath care facility where
patients with COVID-19 acute respiratory disease patients were being treated.</p>

<p class=MsoNormal><u>Clinical criteria</u></p>

<p class=MsoNormal>Severe acute respiratory infection requiring hospital
admission with radiological/clinical signs of pneumonia or respiratory distress
syndrome</p>

<p class=MsoNormal>OR</p>

<p class=MsoNormal>Acute respiratory infection with cough or shortness of
breath (with or without fever)</p>

<p class=MsoNormal>OR</p>

<p class=MsoNormal>Fever with no other symptoms.</p>

<p class=MsoNormal>AND with no other aetiology that fully explains the clinical
presentation</p>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>&nbsp;</p>

<h2>Presenting symptoms and signs</h2>

<p class=MsoNormal>Early recognition of suspected patients allows timely initiation
of infection prevention and control (IPC) measures. Most (80%) symptomatic
patients develop mild disease, an estimated 15% develop severe disease (with
hypoxaemia, dyspnoea and tachypnoea) while 5% become critically ill (with
respiratory failure, septic shock and/or multiorgan dysfunction). The
proportion of asymptomatic carriers is currently unknown.</p>

<p class=MsoNormal>The most common presenting symptoms have been:</p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>fever (~90%, but only present in 44% on admission)</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>cough (68%)</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>fatigue (38%)</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>sputum production (34%)</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>shortness of breath (19%)</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>myalgia or arthralgia (15%)</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>sore throat (14%)</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>headache (13.6%)</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>chills (12%). </p>

<p class=MsoNormal>Gastrointestinal symptoms such as nausea or vomiting (5.0%)
and diarrhoea (3.8%) appear to be uncommon. </p>

<p class=MsoNormal>There have been recent reports of people with COVID-19
presenting with loss of smell (anosmia) and loss of taste (ageusia)</p>

<p class=MsoNormal>The vast majority of cases will make a full recovery,
particularly the low risk adults.</p>

<h2><a name="_Hlk35763554">Examination findings</a></h2>

<p class=MsoNormal>Examinations are non-specific and may range from none other
than fever to severe respiratory distress, shock and multi organ failure.</p>

<h3>Important things to look for</h3>

<h2><span style='font-size:11.0pt;font-weight:normal'>Travel history of anyone
meeting the clinical criteria is key.</span></h2>

<h2>Management at the OPD and Ward</h2>

<p class=MsoNormal>Diagnostic criteria, symptoms, signs and examination
findings are as above.</p>

<p class=MsoNormal>As soon as a possible case is identified the nurse and
doctor in charge should be called. Possible cases should be given a surgical
mask to wear as soon as it is clear that they are a possible case. </p>

<p class=MsoNormal>They should then be transferred as soon as possible into the
negative pressure ward side room using the rear corridor (avoiding transit
through the ward). If the two side rooms are occupied, the Gambian MOH must be
promptly informed on 1025 so that the patient can be evacuated after
nasopharyngeal and throat samples are taken for COVID-19. However, if the
patient is eligible for admission into the MRCG CSD, admit to the COVID-19 bay
on Fajara ward and or the COVID-19 ward at Keneba.</p>

<p class=MsoNormal>For emphasis, the public health authorities (Gambian MOH,
1025) should be alerted that the unit has a possible case. They have the duty
to follow things up and inform the WHO if the results turn out to be positive.</p>

<p class=MsoNormal>Where there is a delay in transit and the patient is well,
they should be taken to chairs behind the seminar room to wait for the side
room to be made ready. If they are unwell one of the OPD rooms should be
vacated for them and access to this room strictly limited.</p>

<p class=MsoNormal>Once a patient has been identified as a possible case, 2
staff should get changed into the appropriate PPE. See SOP-AIR-001 and 002 for
Donning/Doffing PPE for COVID-19. </p>

<h2>Investigations </h2>

<p class=MsoNormal>Investigations should be discussed with the laboratories
prior to sampling so that they can be sure that they are prepared. ALL samples
should be clearly labelled with a sticker and marked as “suspected Coronavirus”</p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Nasopharyngeal and oropharyngeal swab, sputum – For PCR detection
of SARS-CoV-2 after discussion with the molecular lab.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>FBC – Lymphopenia is common, seen in ~80% of patients (Guan et al
,Yang et al). Mild thrombocytopenia is common (but platelets are rarely
&lt;100). Lower platelet count is a poor prognostic sign (Ruan et al 3/3). Also
look for signs of other diseases or coinfection.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>U&amp;Es – renal failure can be a complication of sepsis.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>LFTs – may give signs of alternative diagnosis (eg biliary
sepsis).</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Malaria RDT &amp; slide – looking for signs of other diseases or
coinfection. Note that it is safe to do an RDT at the bedside using a capillary
blood sample.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Blood sugar – it is safe to do blood sugar at the bedside using a
capillary sample. </p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>HIV – looking for signs of other diseases or coinfection.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Chest X-ray – should NOT be performed until COVID-19 has been
ruled out as there is a risk of contamination. If/when available, the portable
Xray machine will be used for all chest X-rays.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>ECG – if there is arrhythmia. </p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>USS – bedside USS may be helpful in the absence of CXR. Remember
that the probe and all parts that enter the negative pressure room must be
decontaminated after use. </p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Other tests that are clinically indicated.</p>

<p class=MsoNormal><b><span style='font-size:12.0pt'>Treatment on the Ward</span></b></p>

<p class=MsoNormal>There is no specific treatment for COVID-19.</p>

<p class=MsoNormal>Patient with confirmed COVID-19 with <b>mild disease</b>
such as fever, cough, sore throat, fatigue, headache, muscle pain and nasal
congestion may be managed at home with strict instructions to self-isolate at
home where they will be followed up by public health officials and be given
appropriate advice about reducing possible transmission to others. See guidance
on Self-isolation for Coronavirus issued by MRCG at LSHTM.</p>

<p class=MsoNormal>Currently in the Gambia however, people with mild disease
are being admitted to ensure isolation and decrease the probability of
community/local transmission. This might however change as the pandemic unfolds
locally.</p>

<p class=MsoNormal>Confirmed patients with <b>moderate</b> to <b>severe </b>cases
with pneumonia manifestations  who meet any of the following criteria: respiratory
rate ≥ 30 breaths/min; oxygen saturation ≤ 93% at a rest state; Heart rate &gt;
120 bpm, temperature &gt; 39 and altered mental state must be hospitalized to
receive supportive therapy. This is covered in another guideline.</p>

<p class=MsoNormal>All patients must be assessed for severity and a decision
made about plans for treatment escalation at the time of admission. This is
covered in another guideline.</p>

<p class=MsoNormal><b>Give supplemental oxygen therapy immediately to patients
with low oxygen saturation.</b> </p>

<p class=MsoNormal>Oxygen therapy is likely to be the single most effective
supportive measure in COVID-19 patients overall. Target SpO2 ≥90% in
non-pregnant adults and SpO2 ≥92-95 % in pregnant patients. Titrate oxygen
therapy up and down to reach targets by means of nasal cannula, a simple face
mask or a face mask with reservoir bag, as appropriate.</p>

<p class=MsoNormal><b>Use conservative fluid management in patients with SARS
when there is no evidence of shock.</b>  Aggressive fluid resuscitation may
worsen oxygenation, especially in settings where there is limited availability
of mechanical ventilation.</p>

<p class=MsoNormal><b>If a clinical suspicion for co-infection exists, consider
empiric antimicrobials to treat co-pathogens causing the syndrome, particularly
in severe cases</b>. This may include conventional and atypical bacterial
pathogens, malaria, influenza and PCP. </p>

<p class=MsoNormal>Although there is no clinical evidence for effective
antiviral drugs, lopinavir-ritonavir combination as well as antibacterial, azithromycin
and antimalarial drug, hydroxychloroquine are being studied at the moment. Use
of antiviral or anti-inflammatory medications should be used only as part of a
clinical trial.</p>

<p class=MsoNormal>Closely monitor patients for signs of clinical
deterioration, such as rapidly progressive respiratory failure and sepsis, and
apply supportive care interventions. </p>

<p class=MsoNormal><b>Differential diagnosis</b> </p>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Influenza (remembering the seasonality in patients from the
northern hemisphere differs from those of the southern hemisphere)</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Both conventional and atypical bacterial pneumonias,</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>In patients with HIV and a CD4 count &lt;200 cells/mm3 (or
equivalent immunosuppression), <i>Pneumocystis jiroveci</i> pneumonia. </p>

<p class=MsoNormal><b>Discharge and deisolation criteria</b> </p>

<p class=MsoNormal>Patients with COVID-19 can be discharged home from OPD or
isolation room provided the meet ALL of the following criteria: </p>

<p class=MsoNormal>1. There are no medical indications for admission. </p>

<p class=MsoNormal>2. The patient’s symptoms have improved or resolved. (Note:
full recovery can take several weeks, especially in severe cases. It is not
necessary for every symptoms to have completely resolved prior to discharge,
only that there has been improvement).</p>

<p class=MsoNormal> 3. The patient has two consecutive negative combined
nasopharyngeal and oropharyngeal RT-PCR tests, performed at least 24-48 hours
apart.  </p>

<p class=MsoNormal>Patients with mild disease who were managed at home from the
outset can be deisolated using the same criteria.</p>

<span style='font-size:11.0pt;font-family:"Arial","sans-serif"'><br clear=all
style='page-break-before:always'>
</span>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b><span
style='font-size:12.0pt'>&nbsp;</span></b></p>

<h2>Key Issues for Nursing care</h2>

<p class=MsoListParagraphCxSpFirst style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>All patients being seen in Gate clinic or OPD with any one of
cough, shortness of breath or fever starting in the last 14 days MUST be asked
about travel.</p>

<p class=MsoListParagraphCxSpMiddle style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>All nursing staff entering a side room containing a patient, or
caring for a patient in another setting, with suspected or proven COVID-19 must
wear PPE as outlined in the SOP.</p>

<p class=MsoListParagraphCxSpLast style='text-indent:-18.0pt'><span
style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>All staff that have contact with the patient must enter the
details into the log book provided. </p>

<h2>References</h2>

<p class=MsoNormal><span style='font-size:10.0pt'>Handbook of COVID-19
prevention and treatment </span><span lang=EN-US><a
href="https://video-intl.alicdn.com/Handbook%20of%20COVID-19%20Prevention%20and%20Treatment%20%28Standard%29.pdf?spm=a3c0i.14138300.8102420620.download.6df3647ft8yaHa&amp;file=Handbook%20of%20COVID-19%20Prevention%20and%20Treatment%20%28Standard%29.pdf"><span
lang=EN-GB style='font-size:10.0pt'>https://video-intl.alicdn.com/Handbook%20of%20COVID-19%20Prevention%20and%20Treatment%20%28Standard%29.pdf?spm=a3c0i.14138300.8102420620.download.6df3647ft8yaHa&amp;file=Handbook%20of%20COVID-19%20Prevention%20and%20Treatment%20%28Standard%29.pdf</span></a></span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>Clinical management of
suspected or confirmed COVID-19 disease </span><span lang=EN-US><a
href="http://www.health.gov.za/index.php/component/phocadownload/category/628"><span
lang=EN-GB style='font-size:10.0pt'>http://www.health.gov.za/index.php/component/phocadownload/category/628</span></a></span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>WHO technical guidance for
2019-nCoV. </span><span lang=EN-US><a
href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance"><span
lang=EN-GB style='font-size:10.0pt'>https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance</span></a></span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>Novel Coronavirus (2019-nCov)
Guidance for Health professionals collection. </span><span lang=EN-US><a
href="https://www.gov.uk/government/collections/wuhan-novel-coronavirus"><span
lang=EN-GB style='font-size:10.0pt'>https://www.gov.uk/government/collections/wuhan-novel-coronavirus</span></a></span><span
style='font-size:10.0pt'>  </span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>Guan WJ, Ni ZY, Hu Y, Liang
WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019
in China. N Engl J Med. 2020.</span></p>

<p class=MsoNormal><span style='font-size:10.0pt'>Yang J, Zheng Y, Gou X, Pu K,
Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y, Prevalence of comorbidities in the
novel Wuhan coronavirus (COVID-19) infection: a systematic review and
meta-analysis, International Journal of Infectious Diseases (2020), doi: </span><span
lang=EN-US><a href="https://doi.org/10.1016/j.ijid.2020.03.017"><span
lang=EN-GB style='font-size:10.0pt'>https://doi.org/10.1016/j.ijid.2020.03.017</span></a></span><span
style='font-size:10.0pt'> </span></p>

<p class=MsoNormal><span style='font-size:10.0pt;background:#FCFCFC'>Ruan, Q.,
Yang, K., Wang, W. <i>et al.</i> Clinical predictors of mortality due to
COVID-19 based on an analysis of data of 150 patients from Wuhan, China. <i>Intensive
Care Med </i>(2020). https://doi.org/10.1007/s00134-020-05991-x</span></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Written
  by:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Name: Amie
  Secka</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Date: 25
  March 2020</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Reviewed
  by:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Name: Babatunde
  Awokola</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Date: 10
  April 2020</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Version:</b></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Change
  history:</b></p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>Review
  due date:</b></p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>1.0</p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>New document</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>10 April
  2022</p>
  </td>
 </tr>
 <tr style='height:1.0pt'>
  <td width=143 valign=bottom style='width:106.95pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>Review
  Comments (<i>if applicable)</i></p>
  </td>
  <td width=241 valign=bottom style='width:181.1pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'>&nbsp;</p>
  </td>
  <td width=191 valign=bottom style='width:143.45pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:1.0pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><b>&nbsp;</b></p>
  </td>
 </tr>
</table>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>                                                          </p>

</div>

</body>

</html>
